SCHEMBL28049209

SCHEMBL28049209

O=C(OF)c1ccc(Br)cn1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.60
ALDH1A1 P00352 2/20 0.60
MAPK1 P28482 2/20 0.42
ADORA3 P0DMS8 3/20 0.37
L3MBTL1 Q9Y468 3/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
TSHR P16473 1/20 0.36
GAA P10253 1/20 0.36
PLAU P00749 1/20 0.35
ADRA2A P08913 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
ATM Q13315 1/20 0.35
RECQL P46063 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30978460 0.81 MAPK1 (0.65) KDM4EALDH1A1MAPK1L3MBTL1NPC1
SCHEMBL109364 0.81 MAPK1 (0.65) KDM4EALDH1A1MAPK1L3MBTL1NPC1
SCHEMBL28020808 0.81 KDM4E (0.60) KDM4EALDH1A1MAPK1ADORA3L3MBTL1
SCHEMBL28048179 0.78 MAPK1 (0.43) KDM4EALDH1A1MAPK1L3MBTL1KMT2A
SCHEMBL15932170 0.78 KDM4E (0.56) KDM4EALDH1A1MAPK1ADORA3L3MBTL1
SCHEMBL16179277 0.78 KDM4E (0.51) KDM4EALDH1A1MAPK1ADORA3L3MBTL1
SCHEMBL31407736 0.77 KDM4E (0.55) KDM4EALDH1A1MAPK1NPC1RAB9A
SCHEMBL1808295 0.77 ALDH1A1 (0.55) KDM4EALDH1A1MAPK1MEN1NPC1
SCHEMBL645688 0.77 KDM4E (0.55) KDM4EALDH1A1MAPK1NPC1RAB9A
SCHEMBL28934033 0.77 ALDH1A1 (0.55) KDM4EALDH1A1MAPK1ADORA3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103492386-B Novel compounds useful for the treatment of degenerative and inflammatory diseases GALAPAGOS N.V. (BE) 2016-03-09 CN disclosed